Cite
HARVARD Citation
Papp, K. et al. (2019). Granulocyte–macrophage colony‐stimulating factor (GM‐CSF) as a therapeutic target in psoriasis: randomized, controlled investigation using namilumab, a specific human anti‐GM‐CSF monoclonal antibody. British journal of dermatology. pp. 1352-1360. [Online].